期刊文献+

不同细胞因子在体外诱导耐受性树突状细胞的作用

下载PDF
导出
出处 《重庆医学》 CAS CSCD 北大核心 2010年第17期2374-2376,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(30260039) 江西省自然科学基金资助项目(2007GZY2599)
  • 相关文献

参考文献19

  • 1Weng Y,Sun J,Wu Q,et al. Regulatory effects of vasoaerive inlestinal peptide on the migration of mature dendritic cells[J].J Neuroimmunol, 2007,182(1-2) : 48.
  • 2Gonzalez-Rey E, Delgado M. Role of vasoactive intestinal peptide in inflammation and autoimmunity[J]. Curr Opin Investig Drugs,2005,6(11) : 1116.
  • 3Delgado M, Chorny A, Ganea D, et al. Vasoactive intestinal polypeptide induces regulatory dendritic cells that pre vent acute graft versus host disease and leukemia relapse after bone marrow transplantation[J].Ann N Y Acad Sci, 2006,1070 : 226.
  • 4Chorny A, Gonzalez-Rey E, Delgado M. Regulation of dendritic cell differentiation by vasoactive intestinal pep tide: therapeutic applications on autoimmunity and transplantation[J]. Ann N Y Acad Sci, 2006,1088 : 187.
  • 5Gonzalez-Rey E, Chorny A, Fernandez-Martin A, et al. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells[J]. Blood, 2006,107 (9) : 3632.
  • 6Delgado M,Gonzalez-Rey E, Ganea D. Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis[J].Ann N Y Acad Sci,2006,1070:233.
  • 7邱勇,李冬妹,何秀娟,张罕,李静,梁胜男,胡永秀.雷帕霉素和地塞米松对小鼠树突状细胞分化成熟的调控[J].细胞与分子免疫学杂志,2006,22(5):582-584. 被引量:4
  • 8Griffiths KL, O'Neill HC. Dendritic cells as immune regulators:the mouse model[J]. J Cell Mol Med, 2008, 12 (5B) :1909.
  • 9Salazar L, Aravena O, Contreras-Levicoy J. et al. Short term lipopolysaccharide stimulation induces differentiation of murine bone marrow-derived dendritic cells into a tolerogenic phenotype [ J ]. Eur Cytokine Netw, 2007, 18 (2) :78.
  • 10Anderson AE, Swan DJ, Sayers BL,et al. LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells[J]. J Leukoc Biol, 2009,85 (2) :243.

二级参考文献11

  • 1王云甫,孙圣刚,何国厚,陈吉相,杨敬宁,李罗清,曹学兵,吴雄文.体外诱导扩增大鼠树突状细胞及其特性鉴定[J].细胞与分子免疫学杂志,2005,21(1):76-78. 被引量:14
  • 2Carl G,I Jolanda M,W Joost L.Dendritic cell immunotherapy:mapping the way[J].Nature Medi,2004,10(5):475-480.
  • 3Holger H,Adrian E,Angus W.Designer dendritic cells for tolerance induction:guided not misguided missiles[J].Trends Immunol,2001,22(8):437-442.
  • 4Beriou G,Peche H,Guillonneau C,et al.Donor-specific allograft tolerance by administration of recipient-derived immature dendritic cells and suboptimal immunosuppression[J].Transplantation,2005,79(8):969-972.
  • 5Steinman RM,Hawiger D,Nussenzweig MC.Tolerogenic dendritic cells[J].Annu Rev Immunol,2003,21:685-711.
  • 6Randall L,Guy S,Diana D,et al.Visualizing dendritic cell networks in vivo[J].Nat Immunol,2004,12(5):1243-1250.
  • 7Kishimoto K,Dong VM,Sayegh MH,et al.The role of costimulatory molecules as targets for new immunosuppressives in transplantation[J].Curr Opini Urol,2000,10(2):57-62.
  • 8Habiro K,Kotani M,Omoto K,et al.Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice[J].Transplantation,2003,76(5):854-858.
  • 9Sun W,Can L,Kyung A,et al.Cyclosporine-induced renal injury induces Toll-like receptor and maturation of dendritic cells[J].Transplantation,2005,80(5):691-699.
  • 10Yu XZ,Carpenter P,Anasetti C.Advances in transplantation tolerance[J].Lancet,2001,357:1959-1963.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部